EDUCATION

Undergraduate - B -S - in Biology
  • University of California San Diego , San Diego , California

Medical School

  • University of Southern California School of Medicine , Los Angeles , California

Internship

Combined Residency Program in Pediatrics Primary Care
  • Boston Children's Hospital (Harvard Medical School) and Boston Medical Center (Boston University Medical School) , Boston , MA

Graduate Degree

Combined Program in Pediatrics Primary Care Track
  • Boston Children's Hospital (Harvard Medical School) and Boston Medical Center (Boston University Medical School) , Boston , MA

Fellowship

Pediatric Gastroenterology - Hepatology - and Nutrition
  • University of California , San Diego , CA

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Rubinstein E, Hait EE, Mitchell PD, Lee JJ. Every-other-day Dosing of Oral Viscous Budesonide Is not Effective in the Management of Eosinophlic Esophagitis. J Pediatr Gastroenterol Nutr. 2018 Mar; 66(3):395-397. View abstract
  2. Rubinstein E, Lee JJ, Fried A, Logvinenko T, Ngo P, McDonald D, Hait EJ. Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr. 2014 Sep; 59(3):317-20. View abstract
  3. Rubinstein E, Stolz LE, Sheffer AL, Stevens C, Bousvaros A. Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency. BMC Gastroenterol. 2014 Apr 09; 14:71. View abstract
  4. Rosen R, Amirault J, Johnston N, Haver K, Khatwa U, Rubinstein E, Nurko S. The utility of endoscopy and multichannel intraluminal impedance testing in children with cough and wheezing. Pediatr Pulmonol. 2014 Nov; 49(11):1090-6. View abstract
  5. Lee JJ, Fried AJ, Hait E, Yen EH, Perkins JM, Rubinstein E. Topical inhaled ciclesonide for treatment of eosinophilic esophagitis. J Allergy Clin Immunol. 2012 Oct; 130(4):1011; author reply 1011-2. View abstract
  6. Rubinstein E, Cho JY, Rosenthal P, Chao J, Miller M, Pham A, Aceves SS, Varki A, Broide DH. Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2011 Oct; 53(4):409-16. View abstract
  7. Rubinstein E, Lavine JE, Schwimmer JB. Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease. Semin Liver Dis. 2008 Nov; 28(4):380-5. View abstract